The Efficacy and Safety of 4-n-butylresorcinol 0.1% Cream for the Treatment of Melasma: A Randomized Controlled Split-face Trial.

Source:http://linkedlifedata.com/resource/pubmed/id/20548876

Download in:

View as

General Info

PMID
20548876